Figure 3. A) This study had an effectiveness freedom form event rat of 59.9%, which met the performance goal of 50%. Notably, examination of components of the composite efficacy endpoint (B) revealed differential contributions over time of the distinct components. Examination of Anti-arrhythmic drug usage in study patients over time (C) showed that usage of Class I/III drugs dropped dramatically over the course of the study.